DC Circ. Asks What's Wrong With Endo-Impax Deal
By Matthew Perlman · May 1, 2023, 8:35 PM EDT
A D.C. Circuit panel questioned an attorney for the Federal Trade Commission on Monday about what makes a 2017 settlement between Endo Pharmaceuticals and Impax over an opioid medication that the...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login